Evidence map›Paper›PMID 24788318›Full record

ArticlePLoS pathogens2014

HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon.

Michael A Chattergoon, Rachel Latanich, Jeffrey Quinn, Matthew E Winter, Robert W Buckheit, Joel N Blankson, Drew Pardoll, Andrea L Cox

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 2 syntheses or guidelines pooled it, 177 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Targeting inflammasomes as a therapeutic potential for HIV/AIDS.Cellular and molecular life sciences : CMLS · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Heat-KilledNutrients · 2023
    Article
  17. The impact of cannabinoids on inflammasome signaling in HIV-1 infection.NeuroImmune pharmacology and therapeutics · 2023
    Review
  18. Article
  19. Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael A ChattergoonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Rachel LatanichDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Jeffrey QuinnDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Matthew E WinterDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Robert W BuckheitDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Joel N BlanksonDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Drew PardollDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Andrea L CoxDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
HIV and Hepatitis C Pathogenesis & The Human GenomeR01DA013324 · NIDA · JOHNS HOPKINS UNIVERSITY · PI THOMAS, DAVID L · 1999 to 2018
$12.0M
Training Program in Cellular and Molecular MedicineT32GM008752 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI RAO, RAJINI · 2000 to 2019
$11.7M
Scientific CoreU19AI088791 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2010 to 2020
$8.2M
Antibody-Mediated Suppression of Antiviral Inflammasome ActivationR01AI108403 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2013 to 2017
$2.2M
Mechanisms of Immune Evasion by Hepatitis C VirusR01AI077757 · NIAID · JOHNS HOPKINS UNIVERSITY · PI COX, ANDREA L · 2009 to 2012
$1.7M
Recognition of HIV by the Inflammasome Signaling ComplexK08AI102696 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHATTERGOON, MICHAEL ANAND · 2013 to 2017
$937k
NIAID NIH HHS K08 AI102696NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI077757NIAID NIH HHS R01 AI108403NIAID NIH HHS R01AI108403NIAID NIH HHS U19 AI088791NIAID NIH HHS U19 AI09025NIDA NIH HHS R01 DA013324NIGMS NIH HHS T32 GM008752
6 · The paper itself

Abstract

Innate immune sensing of viral infection results in type I interferon (IFN) production and inflammasome activation. Type I IFNs, primarily IFN-α and IFN-β, are produced by all cell types upon virus infection and promote an antiviral state in surrounding cells by inducing the expression of IFN-stimulated genes. Type I IFN production is mediated by Toll-like receptor (TLR) 3 in HCV infected hepatocytes. Type I IFNs are also produced by plasmacytoid dendritic cells (pDC) after sensing of HIV and HCV through TLR7 in the absence of productive pDC infection. Inflammasomes are multi-protein cytosolic complexes that integrate several pathogen-triggered signaling cascades ultimately leading to caspase-1 activation and generation pro-inflammatory cytokines including interleukin (IL)-18 and IL-1β. Here, we demonstrate that HIV and HCV activate the inflammasome, but not Type I IFN production, in monocytes and macrophages in an infection-independent process that requires clathrin-mediated endocytosis and recognition of the virus by distinct endosomal TLRs. Knockdown of each endosomal TLR in primary monocytes by RNA interference reveals that inflammasome activation in these cells results from HIV sensing by TLR8 and HCV recognition by TLR7. Despite its critical role in type I IFN production by pDCs stimulated with HIV, TLR7 is not required for inflammasome activation by HIV. Similarly, HCV activation of the inflammasome in monocytes does not require TLR3 or its downstream signaling adaptor TICAM-1, while this pathway leads to type I IFN in infected hepatocytes. Monocytes and macrophages do not produce type I IFN upon TLR8 or TLR7 sensing of HIV or HCV, respectively. These findings reveal a novel infection-independent mechanism for chronic viral induction of key anti-viral programs and demonstrate distinct TLR utilization by different cell types for activation of the type I IFN vs. inflammasome pathways of inflammation.

Indexed as

Cells, CulturedCytokinesEndocytosisEndosomesHepacivirusHepatitis CHep G2 CellsHIV-1HIV InfectionsHumansInflammasomesInterferon Type IMacrophagesMonocytesToll-Like ReceptorsVirus InternalizationCytokinesInflammasomesInterferon Type IToll-Like Receptors

Identifiers

PMID24788318
PMCPMC4006909
OpenAlexW2048226187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.